Angiotensin II antagonists vs ACE inhibitors: the debate Gill Higgins Newsletter Article 04 February 2013 Pages: 3 - 5
Is dose-adjusted SC heparin a feasible option in DVT? Newsletter Article 04 February 2013 Pages: 7 - 7
NSAID and analgesic prescribing inappropriate in the UK Newsletter Article 04 February 2013 Pages: 7 - 7
High use of β-agonists linked to increased asthma costs Newsletter Article 04 February 2013 Pages: 8 - 8
Gelatinase inhibitor + cytotoxics cut spread of lung cancer Newsletter Article 04 February 2013 Pages: 8 - 8
Trials begin for unique immunomodulatory anticancer agent Gill Higgins Newsletter Article 04 February 2013 Pages: 9 - 10
Targeting gene therapy to epidermal growth factor receptors Newsletter Article 04 February 2013 Pages: 10 - 10
PAK-200 reduces tumour resistance to paclitaxel and doxorubicin Newsletter Article 04 February 2013 Pages: 11 - 11
Acrivastine/pseudoephedrine effective in allergic rhinitis Newsletter Article 04 February 2013 Pages: 11 - 11
H2-antagonists match omeprazole in H.pylori eradication Newsletter Article 04 February 2013 Pages: 12 - 12
Administering LMWH at home - effective treatment for DVT Newsletter Article 04 February 2013 Pages: 12 - 12
Women’s risk of complications with thrombolytics after MI Newsletter Article 04 February 2013 Pages: 12 - 12
New studies in ischaemic stroke & subarachnoid haemorrhage Robert Carlson Newsletter Article 04 February 2013 Pages: 13 - 14
Verapamil therapy after MI does not reduce mortality Newsletter Article 04 February 2013 Pages: 15 - 15
Antibacterials reduce neonatal morbidity after PROM Newsletter Article 04 February 2013 Pages: 15 - 15
Abciximab trial stopped because of positive results Newsletter Article 04 February 2013 Pages: 16 - 16
Oral cholera vaccines can protect for up to 3 years Newsletter Article 04 February 2013 Pages: 16 - 16
Salmeterol preferred to sodium cromoglycate in adult asthma Newsletter Article 04 February 2013 Pages: 16 - 16
Desipramine effective in alcohol dependence with depression Newsletter Article 04 February 2013 Pages: 16 - 16
High-dose cisplatin of no benefit in ovarian cancer Newsletter Article 04 February 2013 Pages: 18 - 18
Anti-infectives can produce remission in active Crohn’s disease Newsletter Article 04 February 2013 Pages: 19 - 19
Prasterone: new routes of delivery open ‘avenues of research’ Newsletter Article 04 February 2013 Pages: 19 - 19
Modifying HR variability to protect against arrhythmias Newsletter Article 04 February 2013 Pages: 20 - 20
Dexrazoxane protects against doxorubicin-induced cardiotoxicity Newsletter Article 04 February 2013 Pages: 21 - 21
US FDA panels reject somatropin for cachexia in AIDS Newsletter Article 04 February 2013 Pages: 22 - 22
US first market for ganciclovir intraocular implant Newsletter Article 04 February 2013 Pages: 22 - 22
Raltitrexed enters first market for colorectal cancer Newsletter Article 04 February 2013 Pages: 22 - 22